Mechanisms and microbial influences on CTLA-4 and PD-1-based immunotherapy in the treatment of cancer: a narrative review
ConclusionThe creation of oncomicrobiotics may allow many patients receiving anti-CTLA-4 and PD-1 immunotherapy to experience prolonged survival and a better quality of life.
Source: Gut Pathogens - Category: Microbiology Source Type: research
More News: Burkholderia | Burkholderia Cepacia | Cancer | Cancer & Oncology | Gastroenterology | Immunotherapy | Microbiology | Probiotics | Toxicology | Vitamin B | Vitamins